Fatty Liver Disease
Hepatic steatosis compromises microcirculation in the liver
Published in Hepatitis Weekly, February 2nd, 2004
According to recent research from England, "fatty liver or hepatic steatosis, which is the result of the abnormal accumulation of triacylglycerol within the cytoplasm of hepatocytes, is a common histological finding in human liver biopsy specimens that is attributed to the effects of alcohol excess, obesity, diabetes, or drugs. There is a general consensus that fatty liver compromises hepatic microcirculation, the common exchange network upon which hepatic arterial and portal inflows converge, regardless of underlying etiology. A significant reduction in hepatic microcirculation has been observed in human...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2004-02-02)
More Articles from Hepatitis Weekly
- Adverse Drug Effects
Lamivudine prevents rituximab-induced hepatitis B virus reactivation - Hepatitis B Virus
Hepatitis B virus X protein does not impair nucleotide excision repair - Hepatitis C Therapy
Proline 495 could be targeted by small-molecule inhibitors of HCV polymerase - Hepatitis C Virus
FDA approves Pegasys prefilled syringes - Hepatitis C Virus
Hepatitis C glycoprotein expression leads to cryptic intron excision - Hepatology
Entangled signals define the nature of cytotoxic T cell-linked liver injury - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
